Salem VA Medical Center

Salem, Virginia 80113

4 studies enrolling now · 25 studies all time

What they study most

Angina Equivalent, Atrial Fibrillation, Castration-Resistant Prostatic Cancer, Catheter-Related Infections, Catheter-related Infections, Chest Pain, Chronic Kidney Disease, Chronic Kidney Diseases, Cognitive Dysfunction, Coronary Artery Disease, Diabetes Mellitus, Type II, Diabetic Foot Ulcer

Studies at this site

• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity — Recruiting now
• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
• Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease — Recruiting now
• A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer — Running, not enrolling
• Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2) — Completed
• Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers — Completed
• A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia — Running, not enrolling
• Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES) — Running, not enrolling
• Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer — Running, not enrolling
• EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed
• A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder — Completed
• Randomized Evaluation of Patients With Stable Angina Comparing Diagnostic Examinations — Stopped early
• Minds Navigating the Diagnosis of Mild Cognitive Impairment — Status unconfirmed
• Factor XI LICA to Reduce Events Such as Heart Attack and Stroke in Patients Whose Kidneys Are no Longer Able to Work as They Should and Require Treatment to Filter Wastes From the Blood: Focus is on the Safety of BAY2976217 and the Way the Body Absorbs, Distributes and Removes the Study Drug — Completed
• A Safety and Efficacy Study of T0903131 (INT131) Besylate to Treat Type 2 Diabetes Mellitus — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
• A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus — Completed
• Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI — Status unconfirmed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
• GLORIA-AF Registry Program - Second and Third Phases — Completed
• Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI — Available (expanded access)
• Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers — Completed
• Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers — Completed
• A Trial of an Oral Nutritional Supplement in Older Hospitalized Patients - NOURISH Study — Completed
• Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients — Stopped early